CDC801
Based on 1 Customer Validation
CDC801 is a potent and orally active phosphodiesterase 4 (PDE4) and tumor necrosis factor-α (TNF-α) inhibitor with IC50 of 1.1 μM and 2.5 μM, respectively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99.19%
- No. CAS: 192819-27-5
- Fòrmula: C23H24N2O5
- Peso molecular:408.45
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-102040
HispidolTNF-α Inhibitor -
HY-P99056
Utomilumab4-1BB/CD137 Agonist -
HY-P9908
AdalimumabTNF-α Inhibitor -
HY-133122
UCB-9260TNF Signaling Inhibitor -
HY-108847
EtanerceptTNF Inhibitor -
HY-102040R
Hispidol (Standard)TNF-α Inhibitor -
HY-110203
R-7050TNF Receptor Antagonist -
HY-111255A
SPD304 dihydrochlorideTNFα Inhibitor -
HY-111255
SPD304TNFα Inhibitor -
HY-147045
UCB-5307TNF Inhibitor -
HY-N2350
CynaropicrinTNF Receptor Inhibitor -
HY-134471
TNF-α-IN-2TNFα Inhibitor
Ver todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
Descripciòn
IC50 & Target
|
PDE4 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PBMC | IC50 |
2.5 μM
Compound: 3c
|
Inhibition of LPS stimulated Tumor Necrosis Factor-alpha (TNF-alpha) release by human PBMC
Inhibition of LPS stimulated Tumor Necrosis Factor-alpha (TNF-alpha) release by human PBMC
|
[PMID: 9873600] |
| PBMC | IC50 |
2.5 μM
Compound: 6b
|
Inhibition of TNFalpha production in LPS-stimulated human PBMC preincubated before LPS challenge measured after 4 hrs by enzyme immunoassay
Inhibition of TNFalpha production in LPS-stimulated human PBMC preincubated before LPS challenge measured after 4 hrs by enzyme immunoassay
|
[PMID: 19256507] |
| U-937 | IC50 |
1.1 μM
Compound: 3c
|
Inhibition of PDE4 enzyme from U937 cells
Inhibition of PDE4 enzyme from U937 cells
|
[PMID: 9873600] |
In Vitro
The more detailed information refer to the Compound 6b in the reference 1 (PMID:19256507)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
No. CAS 192819-27-5
-
Appearance Solid
-
Peso molecular 408.45
-
Fòrmula C23H24N2O5
-
Color White to off-white
-
SMILES
NC(CC(C1=CC(OC2CCCC2)=C(OC)C=C1)N3C(C4=C(C=CC=C4)C3=O)=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocolo
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureza y Documentación
-
Ficha de datos (269 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Man HW, et al. Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4and tumor necrosis factor-alpha inhibitor. J Med Chem. 2009 Mar 26;52(6):1522-4. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CDC801 Related Classifications
HY-U00179 Related Classifications
Powered by Bioz